Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 4,219 | 9,428 | 3,665 | 1,103 | 825 |
| Operating Income | -4,219 | -9,428 | -3,665 | -1,103 | -825 |
| Interest Expense | 0 | 0 | 0 | 805 | 998 |
| Other Income | 107 | 480 | 2,181 | 298 | 0 |
| Pre-tax Income | -4,112 | -8,949 | -1,485 | -1,611 | -1,823 |
| Income Tax | N/A | N/A | N/A | N/A | 2 |
| Net Income Continuous | -4,112 | -8,949 | -1,485 | -1,611 | -1,825 |
| Net Income | $-4,112 | $-8,949 | $-1,485 | $-1,611 | $-1,825 |
| EPS Basic Total Ops | -28.97 | -204.02 | -186.86 | -504.40 | -907.93 |
| EPS Basic Continuous Ops | -16.26 | -204.01 | -186.87 | -511.06 | -903.35 |
| EPS Diluted Total Ops | -28.97 | -204.02 | -186.86 | -504.40 | -907.93 |
| EPS Diluted Continuous Ops | -16.26 | -204.01 | -186.87 | -511.06 | -903.35 |
| EPS Diluted Before Non-Recurring Items | -28.97 | -204.02 | -187.16 | N/A | N/A |
| EBITDA(a) | $-4,219 | $-9,428 | $-3,665 | $-1,103 | $-825 |